Sign up to save your podcasts
Or
Share Is This the Key to Bevacizumab Use in CRC?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Is This the Key to Bevacizumab Use in CRC?
Dr. David Kerr reports on a plausible study suggesting a link between MMR-deficient colon tumors and response to bevacizumab in the adjuvant setting.
View all episodes
By MedscapeDr. David Kerr reports on a plausible study suggesting a link between MMR-deficient colon tumors and response to bevacizumab in the adjuvant setting.